• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Call for Caution in Overinterpreting Exceptional Outcomes After Radical Surgery for Pancreatic Cancer: Let the Data Speak.

作者信息

Datta Jashodeep, Wilson Gregory C, D'Angelica Michael I, Katz Matthew H G, Maithel Shishir K, Merchant Nipun B, Ahmad Syed A

机构信息

Division of Surgical Oncology, Department of Surgery, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida.

Division of Surgical Oncology, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio.

出版信息

Ann Surg. 2021 Jul 1;274(1):e82-e84. doi: 10.1097/SLA.0000000000004471.

DOI:10.1097/SLA.0000000000004471
PMID:33086320
Abstract
摘要

相似文献

1
A Call for Caution in Overinterpreting Exceptional Outcomes After Radical Surgery for Pancreatic Cancer: Let the Data Speak.对胰腺癌根治术后过度解读异常结果需谨慎：让数据说话。
Ann Surg. 2021 Jul 1;274(1):e82-e84. doi: 10.1097/SLA.0000000000004471.
2
Treatment strategy of intraductal papillary-mucinous tumor of the pancreas.胰腺导管内乳头状黏液性肿瘤的治疗策略
J Gastroenterol. 2005 Jul;40(7):773-4. doi: 10.1007/s00535-005-1648-2.
3
Long-term survival after pancreatoduodenectomy for ductal adenocarcinoma: the emperor has no clothes?胰十二指肠切除术治疗导管腺癌后的长期生存：皇帝没穿衣服？
Pancreas. 2008 Nov;37(4):349-51. doi: 10.1097/MPA.0b013e31818e9100.
4
Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study.早期胰腺导管腺癌的胰体尾切除术：一项单中心病例对照研究
Langenbecks Arch Surg. 2019 Mar;404(2):175-182. doi: 10.1007/s00423-019-01766-1. Epub 2019 Mar 2.
5
Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in one medical center.胰导管腺癌手术切除的 3 年和 5 年结果：一家医疗中心的长期经验。
Asian J Surg. 2018 Mar;41(2):115-123. doi: 10.1016/j.asjsur.2016.11.009. Epub 2016 Dec 20.
6
ASO Author Reflections: The Role of Established Prognostic Factors in Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma.ASO作者反思：既定预后因素在胰腺导管腺癌切除术后长期生存中的作用
Ann Surg Oncol. 2024 Sep;31(9):6199-6200. doi: 10.1245/s10434-024-15391-w. Epub 2024 May 20.
7
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma.ASO作者反思：可切除性胰腺导管腺癌术前生存预测的重要性
Ann Surg Oncol. 2024 Oct;31(10):7074-7075. doi: 10.1245/s10434-024-15853-1. Epub 2024 Jul 17.
8
Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series.血管切除治疗局部进展期胰导管腺癌：单中心系列长期结果分析。
World J Surg Oncol. 2021 Apr 18;19(1):126. doi: 10.1186/s12957-021-02238-x.
9
Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.基于切除术后残留胰腺中复发评估的胰腺主胰管内乳头状黏液性肿瘤的治疗策略：一项回顾性研究。
Ann Surg. 2014 Feb;259(2):360-8. doi: 10.1097/SLA.0b013e3182a690ff.
10
[Surgical treatment of pancreatic carcinoma: problems and recent advances].[胰腺癌的外科治疗：问题与最新进展]
Zhonghua Wai Ke Za Zhi. 2016 Jun 1;54(6):401-403. doi: 10.3760/cma.j.issn.0529-5815.2016.06.001.

引用本文的文献

1
Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicenter prospective trial - trial protocol.FOLFIRINOX化疗后对可切除边缘和局部晚期胰腺癌进行手术可切除性预测（PeRFormanCe）：一项多中心前瞻性试验——试验方案
BMC Surg. 2025 May 13;25(1):204. doi: 10.1186/s12893-025-02938-1.
2
Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2).交界性和局部进展期胰腺癌的切除率和意向治疗结果：一项基于人群、前瞻性队列研究（NORPACT-2）的真实世界数据。
BJS Open. 2023 Nov 1;7(6). doi: 10.1093/bjsopen/zrad137.
3
ASO Practice Guidelines Series: Management of Resectable, Borderline Resectable, and Locally Advanced Pancreas Cancer.
美国血管外科学会实践指南系列：可切除、边缘可切除及局部进展期胰腺癌的管理
Ann Surg Oncol. 2024 Mar;31(3):1884-1897. doi: 10.1245/s10434-023-14585-y. Epub 2023 Nov 19.
4
Design of tables for the presentation and communication of data in ecological and evolutionary biology.生态与进化生物学中数据展示与交流表格的设计
Ecol Evol. 2023 Jul 14;13(7):e10062. doi: 10.1002/ece3.10062. eCollection 2023 Jul.
5
The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer.不可逆电穿孔与化疗在局部晚期胰腺癌治疗中的协同作用
Front Oncol. 2022 May 25;12:843769. doi: 10.3389/fonc.2022.843769. eCollection 2022.
6
Total neoadjuvant therapy for pancreatic adenocarcinoma increases probability for a complete pathologic response.新辅助治疗胰腺癌可增加完全病理缓解的概率。
Eur J Surg Oncol. 2022 Jun;48(6):1356-1361. doi: 10.1016/j.ejso.2021.12.473. Epub 2022 Jan 5.
7
Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma.切除术后胰腺腺癌患者辅助化疗治疗的真实世界模式。
Med Oncol. 2021 Feb 3;38(2):18. doi: 10.1007/s12032-021-01469-y.